A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock

NASuspendedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

January 30, 2022

Primary Completion Date

February 28, 2027

Study Completion Date

May 31, 2027

Conditions
Septic Shock
Interventions
DEVICE

Cytosorb® 300 ml

patients will receive CytoSorb therapy in addition to standard of care therapy according to applicable guidelines

Trial Locations (18)

10117

Department of Nephrology and Medical Intensive Care, Charité - University Medical Center, Berlin

12203

Department of Anesthesiology and Operative Intensive Care Medicine (CBF), Charité - Universitätsmedizin Berlin, Berlin

14467

Center for Emergency and Intensive Care Medicine, Hospital Ernst von Bergmann, Potsdam

17475

Department of Internal Medicine B, Cardiology, Pneumology, Infectious Diseases, Intensive Care Medicine, University Hospital Greifswald, Greifswald

18057

Department of Anesthesiology and Intensive Care Medicine, Rostock University Medical Centre, Rostock

20251

Department of Intensive Care Medicine, University Medical-Center Hamburg-Eppendorf, Hamburg

26721

Klinikum Emden, Emden

32049

Department of Anesthesiology, Surgical Intensive Care, Emergency and Pain Medicine, Ruhr- University Bochum, Klinikum Herford, Herford, Germany, Herford

37075

Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen

45147

Department of Nephrology, University Hospital Essen, Essen

49477

Department of Anesthesiology, Operative Intensive Care Medicine, Pain Management and Emergency Medicine, Hospital Ibbenbüren, Ibbenbueren

60323

Department of Anesthesiology, Intensive-Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main

81675

Department of Internal Medicine II, Technical University of Munich, Munich

99089

Clinic for Interdisciplinary Intensive Care and Intermediate Care, HELIOS Hospital Erfurt, Erfurt

01307

Department of Anesthesiology and Critical Care Medicine, University Hospital of Dresden, Dresden

Unknown

Department of Anaesthesiology, Intensive Care and Pain Therapy, Saarland University Medical Center and Saarland University Faculty of Medicine, Homburg

Department of Anaesthesiology and Intensive Care Medicine, Technical University of Munich, Munich

04103

Department of Internal Medicine, Neurology and Dermatology, Interdisciplinary Internal Intensive Care Medicine, University Leipzig, Leipzig

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BRAHMS GmbH

UNKNOWN

collaborator

MedInnovation GmbH

INDUSTRY

lead

CytoSorbents Europe GmbH

INDUSTRY

NCT04963920 - A RCT to Assess the Performance of CytoSorb for Shock Reversal in Patients With Vasoplegic Septic Shock | Biotech Hunter | Biotech Hunter